home / stock / hmtxf / hmtxf quote
Last: | $0.0371 |
---|---|
Change Percent: | 0.0% |
Open: | $0 |
Close: | $0.0371 |
High: | $0 |
Low: | $0 |
Volume: | 15 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0371 | $0 | $0.0371 | $0 | $0 | 15 | 05-03-2024 |
$0.0371 | $0.0372 | $0.0371 | $0.0372 | $0.0371 | 58,000 | 04-24-2024 |
$0.0371 | $0.0371 | $0.0371 | $0.0371 | $0.0371 | 2,000 | 04-11-2024 |
$0.0451 | $0.0451 | $0.0451 | $0.0451 | $0.0451 | 250 | 04-04-2024 |
$0.0444 | $0.0457 | $0.0444 | $0.0457 | $0.0444 | 19,000 | 04-01-2024 |
$0.0436 | $0.0492 | $0.0436 | $0.0492 | $0.0436 | 25,000 | 03-22-2024 |
$0.0493 | $0.0493 | $0.0493 | $0.0493 | $0.0493 | 3,500 | 03-21-2024 |
$0.05 | $0.0516 | $0.05 | $0.0516 | $0.05 | 24,740 | 03-20-2024 |
$0.055 | $0.055 | $0.055 | $0.055 | $0.055 | 30,000 | 03-11-2024 |
$0.0551 | $0.0551 | $0.0551 | $0.0551 | $0.0551 | 1,000 | 03-08-2024 |
$0.0552 | $0.0552 | $0.0552 | $0.0552 | $0.0552 | 10,000 | 02-29-2024 |
$0.0516 | $0.0516 | $0.0516 | $0.0516 | $0.0516 | 8,260 | 02-27-2024 |
$0.0532 | $0.05225 | $0.0532 | $0.0532 | $0.05225 | 12,845 | 02-26-2024 |
$0.06192 | $0 | $0.06192 | $0 | $0 | 2,200 | 02-22-2024 |
$0.06192 | $0 | $0.06192 | $0 | $0 | 10,000 | 02-21-2024 |
$0.0619 | $0.06192 | $0.06192 | $0.0619 | $0.0619 | 700 | 02-19-2024 |
$0.06192 | $0.06192 | $0.06192 | $0.06192 | $0.06192 | 700 | 02-16-2024 |
$0.0612 | $0.0612 | $0.0612 | $0.0612 | $0.0612 | 800 | 02-15-2024 |
$0.0749 | $0.0749 | $0.0749 | $0.0749 | $0.0749 | 500 | 02-08-2024 |
$0.0727 | $0.0727 | $0.0727 | $0.0727 | $0.0727 | 904 | 02-07-2024 |
News, Short Squeeze, Breakout and More Instantly...
Calgary, Alberta--(Newsfile Corp. - March 7, 2024) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce the non-exclusive engagement of Oak Hill Asset Management Inc. ("OHAM"), an Exempt Market Dealer to provide capital markets advice rel...
Calgary, Alberta--(Newsfile Corp. - February 6, 2024) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce the Journal of Biomedical Research and Environmental Sciences published the Company's Phase II randomized clinical trial results ...
Calgary, Alberta--(Newsfile Corp. - December 29, 2023) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to like to clarify its press release of October 3, 2023. It refered to the private placement of $320,125 . The Company closed the financing i...